About Constellation Pharma
Constellation Pharma is a company based in Cambridge (United States) founded in 2008 was acquired by MorphoSys in June 2021.. Constellation Pharma has raised $349.37 million across 9 funding rounds from investors including Fidelity Investments, MorphoSys and Genentech. The company has 142 employees as of December 31, 2021. Constellation Pharma operates in a competitive market with competitors including BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others.
- Headquarter Cambridge, United States
- Employees 142 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$349.37 M (USD)
in 9 rounds
-
Latest Funding Round
$65 M (USD), Post-IPO
Oct 01, 2019
-
Investors
Fidelity Investments
& 18 more
-
Employee Count
142
as on Dec 31, 2021
-
Acquired by
MorphoSys
(Jun 02, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Constellation Pharma
Constellation Pharma has successfully raised a total of $349.37M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $65 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $65.0M
-
First Round
First Round
(29 Apr 2008)
- Investors Count 18
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Post-IPO - Constellation Pharma | Valuation |
investors |
|
| Apr, 2018 | Amount | Series E - Constellation Pharma | Valuation | Deerfield , Fidelity Investments | |
| Sep, 2016 | Amount | Series D - Constellation Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Constellation Pharma
Constellation Pharma has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Fidelity Investments, MorphoSys and Genentech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
VC & PE firm focused on healthcare sector
|
Founded Year | Domain | Location | |
|
Investments are focused on pharmaceutical, biotechnology, and medical sectors.
|
Founded Year | Domain | Location | |
|
Early-stage investments in US life science startups are focused on.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Constellation Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Constellation Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Constellation Pharma Comparisons
Competitors of Constellation Pharma
Constellation Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BridgeBio, Spark Therapeutics, Alnylam, ATAI and Insitro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and ultra-rare metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Constellation Pharma
Frequently Asked Questions about Constellation Pharma
When was Constellation Pharma founded?
Constellation Pharma was founded in 2008.
Where is Constellation Pharma located?
Constellation Pharma is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Constellation Pharma a funded company?
Constellation Pharma is a funded company, having raised a total of $349.37M across 9 funding rounds to date. The company's 1st funding round was a Series D of $24.3M, raised on Apr 29, 2008.
How many employees does Constellation Pharma have?
As of Dec 31, 2021, the latest employee count at Constellation Pharma is 142.
What does Constellation Pharma do?
Constellation Pharma was founded in 2008 and is based in Cambridge, United States. Operations are centered in the biotechnology sector, where drugs are developed in the field of epigenetics. The pipeline features inhibitors of bromodomain and extra-terminal proteins, which regulate gene expression, along with small molecules targeting EZH2, a histone methyltransferase in the PRC2 complex. Focus is placed on advancing these therapies through research and development.
Who are the top competitors of Constellation Pharma?
Constellation Pharma's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Who are Constellation Pharma's investors?
Constellation Pharma has 19 investors. Key investors include Fidelity Investments, MorphoSys, Genentech, Orbimed, and The Column Group.